agitation.
Conditions
Interventions
Intervention 1: Intervention group: Group A who receive the drug dexmedetomidine. Intervention 2: Control group: Group B who received placebo.
Sponsors
Arak University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: All patients with bipolar disorder referred to Amirkabir Arak Hospital, who are in the treatment service of supervisors and consultants, and the treatment and medication regimen for their bipolar disorder is the same. All bipolar patients who have signed an informed consent form to enter the study. Patients in the age range of 18 to 45 years Patients with BMI in the range of 20 to 30 Patients with bipolar disorder who do not have other psychiatric diseases at the same time. No history of underlying heart, lung, kidney and liver diseases No history of recent CVA or MI Not receiving anticonvulsant drugs. Absence of pregnancy and breastfeeding Not allergic to dexmedetomidine Patients who do not have very severe agitation
Exclusion criteria
Exclusion criteria: All patients who have severe agitation All patients who have a severe allergy or reaction to the drug after injection and need cardiorespiratory support
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Agitation score. Timepoint: After drug injection in ECT recovery department. Method of measurement: Agitation scoring questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFaeghe Rahmani
Arak University of Medical Sciences
Outcome results
None listed